Aaron Pelta
Corporate Officer/Principal en MORPHIC HOLDING, INC. .
Perfil
Aaron Pelta's career history includes former positions as Vice President-Business Development & Transactions at AMAG Pharmaceuticals, Inc. in 2015, and Vice President-Business Development at X4 Pharmaceuticals (Austria) GmbH from 2016 to 2019.
He also holds a current position as Senior Vice President-Business & Development at Morphic Holding, Inc. starting in 2022.
Mr. Pelta obtained an undergraduate degree from Tufts University in 1996 and an MBA from Tuck School of Business at Dartmouth in 2002.
Cargos activos de Aaron Pelta
| Empresas | Cargo | Inicio |
|---|---|---|
| MORPHIC HOLDING, INC. | Corporate Officer/Principal | 01/01/2019 |
Antiguos cargos conocidos de Aaron Pelta.
| Empresas | Cargo | Fin |
|---|---|---|
| X4 Pharmaceuticals (Austria) GmbH | Corporate Officer/Principal | 01/03/2019 |
| AMAG PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/11/2015 |
Formación de Aaron Pelta.
| Tufts University | Undergraduate Degree |
| Tuck School of Business at Dartmouth | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| MORPHIC HOLDING, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
| X4 Pharmaceuticals (Austria) GmbH |
- Bolsa de valores
- Insiders
- Aaron Pelta
